Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2Phase 4 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Respiratory Distress Syndrome 1Pneumonia, Viral 1Neutropenia 1Hematologic Neoplasms 1Cytokine Release Syndrome 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Piperacillin, Tazobactam Drug Combination × Clear all
NCT06422533 2024-06-04

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Instituto Nacional de Cancerologia de Mexico

Phase NA Recruiting
226 enrolled
Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

NCT04394182 2022-03-29

ULTRA-COVID

Fundacion GenesisCare

Phase NA Suspended
15 enrolled

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡